Image

Global Degenerative Disc Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Degenerative Disc Treatment Market, By Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), Treatment (Physical Therapy, Medications, Surgery), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Degenerative Disc Treatment Market

Degenerative Disc Treatment Market Analysis and Size

Degenerative disc diseases are very recurrent and debilitating disorders, and R&D activities surrounding this disease are highly cost-intensive. Henceforth, many fundraising companies and manufacturers are engaged in raising funds for their research on the treatment of degenerative disc diseases. Around 90% of people experience an episode of debilitating back pain later in their lives. Most of people are asymptomatic. Biopharmaceutical companies particularly target oral treatment and peripherally-acting analgesics.

Data Bridge Market Research analyses a growth rate in the global degenerative disc treatment market in the forecast period 2023-2030. The expected CAGR of global degenerative disc treatment market is tend to be around 9.5% in the mentioned forecast period. The market was valued at USD 2279.78 million in 2022, and it would grow upto USD 4712.01 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Degenerative Disc Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Devices (Cervical Spine, Lumbar Spine, Thoracic Spine and Spinal Fusion), Treatment (Physical Therapy, Medications, Surgery),End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Novartis AG (Switzerland), Medtronic (Ireland), Globus Medical (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Zimmer Biomet (U.S.), Amorphex Therapeutics Holdings, Inc (U.S.), Bausch Health Companies Inc. (Canada), B. Braun SE (Germany), RTI Surgical, (Germany), ulrich medical USA (U.S.), Fresenius Kabi AG (Germany), Stryker (U.S.)

Market Opportunities

  • Higher Launch Of Disc Replacement Surgical Devices
  • Rise in elderly population

Market Definition

Degenerative disc treatment is the type of rare inflammatory disease characterized by weakness and muscle inflammation of muscles and muscle pain. It is the group of three diseases that affects adults and children. Although, polymyositis & dermatomyositis are more common in females than males, and dermatomyositis is more common in children than adults. Symptoms includes progressive muscle weakness, difficulty swallowing or breathing, tripping or falling, and fatigue after walking or standing.

Global Degenerative Disc Treatment Market Dynamics

Drivers

  • Increase in Autoimmune Disorders

As per the National Institute of Environmental Health Sciences, more than 80 autoimmune diseases have been identified namely diabetes (type 1), multiple sclerosis, rheumatoid arthritis, lupus, and celiac disease. Increase in the occurrence of these diseases drives the global market. This boosts the growth of the market.

  • Increased Technological Advancements

The market is seemed to witness higher growth because of the several technological advancements by different market players. For instance, in 2013, Zimmer Biomet launched Mobi-C, a two-level artificial disc for patients with issues with two consecutive spinal disc. Additionally, several key manufacturers are focusing on different acquisition strategies to support their product portfolios, which is expected to expand the growth of the degenerative disc disease treatment market. For instance, Centinel Spine in October 2017, entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes.

Opportunities

  • Rise in Elderly Population

As per different surveys, elderly population is more susceptible to suffering from this disease. According to the Aging World reports from 2015, there were around 562 million people 65 and older globally, which increased the disease incidence and fuelled the growth of the degenerative disc treatment market.

  • Higher Launch Of Disc Replacement Surgical Devices

Numerous companies are focusing on launching innovative and technologically advanced products to meet customers' needs, which is expected to boost the degenerative disc disease treatment market growth during the forecast period. For instance, in March 2019, Atlas Spine Inc. announced the launch of HiJak AC expandable cervical interbody fusion device. The product is an expandable cervical interbody fusion device used for spine fusion surgery. The device provides adjustment to both height and lordosis to easily restore lordosis and balance sagittal alignment of the spinal cord.

 Restraints/Challenges

  • Limited Studies and Surveys

There are very limited studies and surveys that is hampering the growth of the market. Only a minimal amount of data are available with respect to the studies. A few studies mainly focused on groups from a single hospital wherein only a limited number of patients are observed. Thus, this hampers the growth of the market.

  • Availability of Alternative Treatments

Alternative therapies such as physiotherapy and special exercises are used to treat degenerative disc disease, which is expected to impede growth of the disease treatment market during the forecast period. For instance, per the data published in the Toronto Physiotherapy Journal in January 2014, physiotherapy is the most preferred first line treatment for degenerative disc disease among the elderly. This acts as a major hindrance for the market.

This global degenerative disc treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global degenerative disc treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Degenerative Disc Treatment Market Scope

The global degenerative disc treatment market is segmented on the basis of devices, treatment, , distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Devices

  • Cervical Spine
  • Lumbar Spine
  • Thoracic Spine
  • Spinal Fusion

Treatment

  • Physical Therapy
  • Medications
  • Surgery

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Degenerative Disc Treatment Market Regional Analysis/Insights

The global degenerative disc treatment market is analysed and market size insights and trends are provided by devices, treatment, distribution channel and end-user as referenced above.

The major countries covered in the global degenerative disc treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global degenerative disc treatment market throughout the forecasted period due to the presence of key drug suppliers, increased research and development activities.

Asia-Pacific dominates the market due to several new studies and innovations.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Degenerative Disc Treatment Market Share Analysis

The global degenerative disc treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global degenerative disc treatment market

Key players operating in the global degenerative disc treatment market include:

  • Novartis AG (Switzerland)
  • Medtronic (Ireland)
  • Globus Medical (U.S.)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Zimmer Biomet (U.S.)
  • Amorphex Therapeutics Holdings, Inc (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • B. Braun SE (Germany)
  • RTI Surgical, (Germany)
  • ulrich medical USA (U.S.)
  • Fresenius Kabi AG (Germany)
  • Stryker (U.S.)

Research Methodology: Global Degenerative Disc Treatment Market  

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-
Why Choose Us


Frequently Asked Questions

The Degenerative Disc Treatment Market is projected to grow at a CAGR of 9.5% during the forecast period by 2030.
The future market value of the Degenerative Disc Treatment Market is expected to reach USD 4712.01 million by 2030.
The major players in the Degenerative Disc Treatment Market are Novartis AG (Switzerland), Medtronic (Ireland), Globus Medical (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Zimmer Biomet (U.S.), Amorphex Therapeutics Holdings, Inc (U.S.), etc.
The countries covered in the Degenerative Disc Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, etc.